Opportunity
Simpler Grants.gov #RFA-HL-26-027
NHLBI HeartShare 2.0 Data Translation Center Single Source Funding Opportunity
Buyer
National Institutes of Health
Posted
September 02, 2025
Respond By
December 15, 2025
Identifier
RFA-HL-26-027
NAICS
541715
The National Heart, Lung, and Blood Institute (NHLBI) at NIH is forecasting a single source funding opportunity for the renewal of the HeartShare 2.0 Data Translation Center (DTC): - Government Buyer: - National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) - Eligible Applicant: - Northwestern University is the only eligible institution for this opportunity - Products/Services Requested: - Coordination of the HeartShare phenomics program - Support for a cohort of patients with heart failure with preserved ejection fraction (HFpEF) - Curation and analysis of existing data from NIH cohorts and clinical trials - Unique/Notable Requirements: - Non-competitive, single source funding (only Northwestern University may apply) - Focus is on research coordination and advanced data analysis services, not on procurement of commercial products or equipment - Companion funding opportunities will support a Clinical Trial Center and up to seven Clinical Centers for new heart failure clinical trial activities - No OEMs or commercial products are specified in this opportunity - Place of Performance: - National Institutes of Health (NIH)
Description
The National Heart, Lung, and Blood Institute (NHLBI) intends to publish a Notice of Funding Opportunity (NOFO) to solicit a single application for the renewal of the Data Translation Center (DTC) for the ongoing HeartShare phenomics program. The DTC will coordinate the overall project, support a cohort of patients with heart failure with preserved ejection fraction (HFpEF), and curate and analyze existing data from NIH cohorts and trials. This NOFO will utilize the U54 activity code and is a non-competitive funding opportunity intended to fund a single award to Northwestern University, pending a meritorious peer-reviewed application. Companion NOFOs will support a Clinical Trial Center and up to seven Clinical Centers for new clinical trial activities recruiting heart failure patients.